Graft-versus-host disease in cyclosporin A-treated rats after syngeneic and autologous bone marrow reconstitution

J Exp Med. 1983 Jul 1;158(1):1-8. doi: 10.1084/jem.158.1.1.

Abstract

Lethally irradiated rats treated with cyclosporin A (CsA) for 20-40 d develop classic graft-versus-host disease (GVHD) when reconstituted with syngeneic or autologous bone marrow, upon discontinuation of CsA, whereas normal rats do not. Syngeneic GVHD may be transferred to irradiated but not normal syngeneic recipients. Normal spleen cells fail to prevent the development or adoptive transfer of syngeneic GVHD.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Bone Marrow / radiation effects
  • Bone Marrow Transplantation*
  • Cyclosporins / administration & dosage
  • Cyclosporins / therapeutic use*
  • Female
  • Graft vs Host Disease / pathology
  • Graft vs Host Disease / prevention & control*
  • Rats
  • Rats, Inbred Lew
  • Spleen / cytology
  • Spleen / transplantation
  • Transplantation, Homologous
  • Transplantation, Isogeneic

Substances

  • Cyclosporins